Issue 2, 2018

Chitosan-coated cerium oxide nanocubes accelerate cutaneous wound healing by curtailing persistent inflammation

Abstract

Inflammation is the initial phase in the healing of cutaneous wounds; however, persistent inflammation will hamper the healing process by generating excess inflammatory cytokines and reactive oxygen species (ROS). Therefore, preventing persistent inflammation and clearing redundant ROS are important strategies in accelerating wound healing. Owing to their unique redox activity, cerium oxide (CeO2) nanoparticles have shown promising potential as antioxidative and anti-inflammatory agents for the treatment of various diseases resulting from oxidative stress. In the present study, we prepared chitosan-coated CeO2 nanocubes (CCNs) and evaluated their cutaneous wound healing potential when topically applied to open excision wounds on adult Sprague Dawley (SD) rats. CCN application significantly increased the wound healing rates and showed superior wound healing capabilities compared to a clinically applied wound healing agent, recombinant human epidermal growth factor (rhEGF). We attribute this superior wound healing ability to their anti-inflammatory ability by decreasing the expression of the inflammatory cytokine tumor necrosis factor-alpha (TNF-α) and increasing the expression of the anti-inflammatory cytokine interleukin-10 (IL-10), as well as to their antioxidative ability by increasing antioxidant enzyme levels. These results suggest that CCNs hold therapeutic potential in treating refractory wounds characterized by persistent inflammation caused by oxidative-stress related diseases such as diabetes.

Graphical abstract: Chitosan-coated cerium oxide nanocubes accelerate cutaneous wound healing by curtailing persistent inflammation

Supplementary files

Article information

Article type
Research Article
Submitted
12 11 2017
Accepted
08 12 2017
First published
11 12 2017

Inorg. Chem. Front., 2018,5, 386-393

Chitosan-coated cerium oxide nanocubes accelerate cutaneous wound healing by curtailing persistent inflammation

X. Huang, L. Li, G. Lyu, B. Shen, Y. Han, J. Shi, J. Teng, L. Feng, S. Si, J. Wu, Y. Liu, L. Sun and C. Yan, Inorg. Chem. Front., 2018, 5, 386 DOI: 10.1039/C7QI00707H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements